Plant-parasitic nematodes are agriculture's largest unmet pest problem. These microscopic worms attack plant roots, causing an estimated $100 billion in worldwide crop damage annually. Pasteuria has developed a patented, cost- effective commercial scale process for the production of Pasteuria bacteria, a naturally occurring predator. These predatory microbes specifically target, infect, and kill selected nematodes-without leaving toxic crop residues. Other organisms remain unharmed, soil and water is left free of contaminants, and there are no known human exposure risks. Additionally, Pasteuria's microbes are highly durable and require no special handling or storage conditions. The company is on pace to file a submission for registration to EPA by mid-2008.
Pasteuria's investment partners include LSP BioVentures (http://www.lspvc.com), a $100 million fund focused on early to mid-staged companies in the areas of agriculture, food and nutrition, health & wellness, biofuels and related platform technologies; Advantage Capital (http://www.advantagecap.com), a venture capital and private equity firm focused on early-stage companies and other investments supporting state and local economic development; and Gordon River Capital (http://www.gulfshorecap.com), an affiliate of Florida Gulfshore Capital, a Naples, FL based private investment firm involved in the development and sale of consumer, industrial, and medical products and services.
Pasteuria Bioscience, founded in 2003, is located
|SOURCE Pasteuria Bioscience, Inc.|
Copyright©2007 PR Newswire.
All rights reserved